-
Jan 13, 2025 | 
onlinelibrary.wiley.com | Xue Li |Yan Wang |Chao Zhang |Jie Lu
Conflicts of Interest The authors declare no conflicts of interest. Supporting Information Filename Description pce15378-sup-0001-Supplementary__Figures_PCE_24_1602.docx2.5 MB Supporting information. pce15378-sup-0002-Supplementary_Table_1_PCE_24_1602_ertgrtg.xlsx16 KB Supporting information. pce15378-sup-0003-Supplementary_Table_2_PCE_24_1602.xlsx11.2 KB Supporting information. References , , , et al. 2019.
-
Dec 11, 2024 | 01358-5&sz=64)
cell.com | Marziyeh Anari |Hamzeh Karimkhanloo |Shuai Nie |Li Dong |Gio Fidelito |Jacqueline A. Bayliss | +11 more
Keywords lipoprotein lipase very low-density lipoprotein tissue communication ceramide phospholipid lipid metabolism Research topic(s) CP: Metabolism Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is defined as steatotic liver disease in the presence of one or more cardiometabolic risk factors, including obesity, type 2 diabetes, and dyslipidemia.1 Metabolic dysfunction-associated steatohepatitis (MASH) is the more severe form of MASLD, and in addition to excess...
-
Oct 14, 2024 | 
mondaq.com | Jie Lu |Yoko Bian
In the last few weeks, the PTAB has granted institution of eight
IPRs filed by Merck on Johns Hopkins patents directed to methods of
treatment using pembrolizumab. The eight patents are generally
directed to methods for treating cancer in a patient having a tumor
that exhibits a high microsatellite instability (MSI-high) or a
mismatch repair (MMR) deficiency status.
-
Oct 8, 2024 | 
jdsupra.com | Yoko Bian |Jie Lu
In the last few weeks, the PTAB has granted institution of eight IPRs filed by Merck on Johns Hopkins patents directed to methods of treatment using pembrolizumab. The eight patents are generally directed to methods for treating cancer in a patient having a tumor that exhibits a high microsatellite instability (MSI-high) or a mismatch repair (MMR) deficiency status.
-
Oct 7, 2024 | 
bigmoleculewatch.com | Jie Lu |Yoko Bian
In the last few weeks, the PTAB has granted institution of eight IPRs filed by Merck on Johns Hopkins patents directed to methods of treatment using pembrolizumab. The eight patents are generally directed to methods for treating cancer in a patient having a tumor that exhibits a high microsatellite instability (MSI-high) or a mismatch repair (MMR) deficiency status.
-
Aug 24, 2024 | 
daily.jstor.org | Livia Gershon |Jie Lu
The icon indicates free access to the linked research on JSTOR. In the early decades of the internet, writers around the world seized the opportunity to freely and easily share their work with others. As languages scholar Jie Lu writes, in China this led to a boom in postmodern stories that blend history with modern pop culture and engage readers as part of the creative process.
-
Jul 24, 2024 | 
onlinelibrary.wiley.com | Xiaofei Hu |li Liu |Ming Xiong |Jie Lu
1 INTRODUCTION Cerebral small vessel disease (CSVD) refers to a range of clinical, imaging, and pathological syndromes caused by various etiologies that affect the cerebral small arteries, brain venules, and capillaries.
-
May 31, 2024 | 
nature.com | Jie Lu
AbstractCross-sectional study. To study the relationship between the structural changes in the cervical spinal cord (C2/3 level) and the sensorimotor function of children with traumatic thoracolumbar spinal cord injury (TLSCI) and to discover objective imaging biomarkers to evaluate its functional status. Xuanwu Hospital, Capital Medical University, China; Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, China.
-
May 21, 2024 | 
frontiersin.org | Jie Lu
Department of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaBackground: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune inflammatory disease of the central nervous system, (CNS) different from multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). While numerous studies have delved into the involvement of thyroid antibodies (ATAbs) and thyroid function in NMOSD and MS.
-
Apr 7, 2024 | 
arxiv.org | Yixuan Li |Feng Liu |Jie Lu
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
